ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,707.50
34.50 (2.06%)
Last Updated: 12:09:32
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  34.50 2.06% 1,707.50 1,706.50 1,707.50 1,712.50 1,673.00 1,685.50 2,048,203 12:09:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.22 70.09B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,673p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.09 billion. Gsk has a price to earnings ratio (PE ratio) of 14.22.

Gsk Share Discussion Threads

Showing 13751 to 13774 of 33125 messages
Chat Pages: Latest  557  556  555  554  553  552  551  550  549  548  547  546  Older
DateSubjectAuthorDiscuss
08/2/2017
12:24
Core all looks strong to me:

Core results
2016 Growth Q4 2016 Growth
------------ ------------
GBPm .....CER% .....GBP%..... GBPm .....CER% .....GBP%
------- ----- ----- -------- ----- -----

Turnover 27,889 .....6 .....17 .....7,586 .....3 .....21
Core operating
profit 7,771..... 14..... 36 .....2,062..... 16 .....52
Core earnings
per share 102.4p .....12 .....35 .....26.1p..... 11..... 45

tradermichael
08/2/2017
12:24
15.18. at 12.1919, hopefully a good omen ).
essentialinvestor
08/2/2017
12:22
Added some more, nice 23p divi in just a couple of weeks.
woodhawk
08/2/2017
12:20
Added back 40% of what I sold.
essentialinvestor
08/2/2017
12:18
Focus on CER - okish to me.

An extra £2bn pumped into intangibles - what is that - future amortisation costs.

alphorn
08/2/2017
12:14
But the share price down 2.7%.Does not make any sense,but there you go,thats the market for you.Will probably finish up on the day,by the close hopefully.Just bounced off 1516
garycook
08/2/2017
12:13
It had spiked up initially then crashed down the same amount when I made my comment.Since then it has continued falling. As you point out the market has now made its mind up. It didn't like it.
adh0
08/2/2017
12:13
Not to me tbh, CORE EPS outlook for '17 looked on the lower side, but that is just a
quick read through, sold a few on the mini bounce.

As mentioned earlier AZN on resultswas pushed lower, then bounced back quickly.

essentialinvestor
08/2/2017
12:12
Sp Cant seem to make up it s mind ??It down 2.6% Clearly market dint like it .
robrah
08/2/2017
12:11
Looks fine to me also.
spcecks
08/2/2017
12:08
All looks fine to me. Not exceptional but certainly as expected. Dividend outlook maintained which in itself is now almost 5%. Everything that should be up was up. The share price can't seem to make its mind up at the moment though.
adh0
08/2/2017
10:56
Resistance levels 1596p & 1715p. Support 1510p
ny boy
08/2/2017
08:51
With AZN we saw a plunge lower then a sharp recovery, may be a very different
reaction with GSK, but just thought I would mention.

essentialinvestor
08/2/2017
08:49
lol

I would hope their clinical trial data is a little more accurate! ).

essentialinvestor
08/2/2017
08:18
Yes, results at 12.00 noon, webcast at 14.30pm

(Note, the website says 12.00 BST, - could be an error as they also say 07:00 EST (which is currently 5h difference), so going for 12.00 GMT)

tradermichael
08/2/2017
08:03
What time are the Results 12 Noon ?
garycook
08/2/2017
07:59
GSK shares have climbed nearly 11 percent over the past year, as compared with a more than 23-percent rise in the Footsie. Today's results are expected to show 11-12% growth. When will this be mirrored to the market, with a significant upward rating of the share price?
tradermichael
07/2/2017
21:58
LOL - what a ridiculous headline - the chart they print shows prices recovered almost immediately (from a drop of less than 1%) and ended up a piffling 0.36% down. Clearly no one takes that buffoon seriously. The sooner they impeach the moron the better.
woodhawk
07/2/2017
20:46
Trump Sinks Drug Stocks Again on Medicare Drug Price Negotiation
philanderer
07/2/2017
09:21
Hopefully.
essentialinvestor
07/2/2017
09:16
Looks like a big day tomorrow and doubt that AW will want to bow out under a cloud. Good numbers could establish a longer term trend here.
ygor706
06/2/2017
15:07
Looking forward to the nos on Wednesday
ny boy
05/2/2017
21:19
GSK gets a buy rec in the Sunday Times Business section.
joshgroeny
03/2/2017
08:23
GSK is scheduled to report fourth-quarter 2016 and full-year results on 8th Feb. Last quarter, the company delivered a positive earnings surprise of 7.79%.
tradermichael
Chat Pages: Latest  557  556  555  554  553  552  551  550  549  548  547  546  Older

Your Recent History

Delayed Upgrade Clock